Literature DB >> 11857345

Transformation of the microvascular system during multistage tumorigenesis.

Eduard Ryschich1, Jan Schmidt, Günter J Hämmerling, Ernst Klar, Ruth Ganss.   

Abstract

Simian virus SV40 large T Antigen expression in the islets of Langerhans of transgenic mice results in beta-cell hyperproliferation, onset of new blood vessel formation and the development of highly vascularized solid tumors. Angiogenesis in the RIPTag mouse model, as well as in human cancer, is a hallmark of multistage tumorigenesis and precedes the development of solid tumors. In our study, intravital microscopy was used to monitor changes in the blood vessel phenotype, microcirculation and leukocyte adhesion during the progression from normal islets to angiogenic islets and solid tumors. In RIP1-Tag5 mice, an aberrant microangioarchitecture becomes apparent in early stages during spontaneous tumor development. Notably, the transition from normal to angiogenic islets is characterized by an increase in vessel diameter rather than vessel numbers. Thus, dilatation of existing vessels precedes vessel sprouting. Once initiated, neovascularization in angiogenic islets results in loss of vessel hierarchy and differentiation. Solid insulinomas display a higher vessel density and even more dramatic vessel heterogeneity as revealed by local "hot spots" of neovascularization and irregular vessel diameters. Strikingly, profound changes in the microangioarchitecture are already observed in early angiogenic islets suggesting that key features of the angiogenic vasculature are established prior to the expansion of tumor mass. Moreover, adhesion of leukocytes was found to be dramatically decreased in both angiogenic islets and solid tumors and correlates with morphological alterations of the vasculature. Thus, vessel transformation and reduced leukocyte-endothelium interactions are not exclusively features of solid tumors but represent early events during tumorigenesis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857345     DOI: 10.1002/ijc.10074

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy.

Authors:  Basel Sitohy; Janice A Nagy; Shou-Ching Shih Jaminet; Harold F Dvorak
Journal:  Cancer Res       Date:  2011-09-21       Impact factor: 12.701

2.  IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46.

Authors:  Maya Eisenring; Johannes vom Berg; Glen Kristiansen; Elisabeth Saller; Burkhard Becher
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

Review 3.  Stimulation of autoimmunity by toll-like receptor ligands.

Authors:  A Limmer; R Ganss; N Garbi; B Arnold; G J Hämmerling
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

4.  Chemokines direct endothelial progenitors into tumor neovessels.

Authors:  Herbert Spring; Thomas Schüler; Bernd Arnold; Günter J Hämmerling; Ruth Ganss
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

Review 5.  Islet vasculature as a regulator of endocrine pancreas function.

Authors:  Nikiforos Ballian; F Charles Brunicardi
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

Review 6.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

7.  Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells.

Authors:  Rafael Carretero; Ibrahim M Sektioglu; Natalio Garbi; Oscar C Salgado; Philipp Beckhove; Günter J Hämmerling
Journal:  Nat Immunol       Date:  2015-04-27       Impact factor: 25.606

8.  Immune escape mechanism: defective resting and stimulated leukocyte-endothelium interaction in hepatocellular carcinoma of the rat.

Authors:  Sasa-Marcel Maksan; Patrick Morad Araib; Eduard Ryschich; Martha Maria Gebhard; Jan Schmidt
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

9.  Adaptive Immune Responses and HER2/neu Positive Breast Cancer.

Authors:  Eric D Mortenson; Yang-Xin Fu
Journal:  Curr Pathobiol Rep       Date:  2013-03

10.  Implanted microvessels progress through distinct neovascularization phenotypes.

Authors:  Sara S Nunes; Kevin A Greer; Chad M Stiening; Helen Y S Chen; Kameha R Kidd; Mark A Schwartz; Chris J Sullivan; Harish Rekapally; James B Hoying
Journal:  Microvasc Res       Date:  2009-10-13       Impact factor: 3.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.